{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:45:14Z","timestamp":1793144714896,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.aohep.2024.101509","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:09:15Z","timestamp":1714986555000},"page":"101509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-3531","authenticated-orcid":false,"given":"Stephen E.","family":"Congly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Brahmania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aohep.2024.101509_bib0001","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2023.06.026","article-title":"Trends in Medicare Spending on Oral Medications for Hepatitis B From 2013 to 2020","volume":"165","author":"Ying","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101509_bib0002","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.9778\/cmajo.20180108","article-title":"Variable access to antiviral treatment of chronic hepatitis B in Canada: a descriptive study","volume":"7","author":"Congly","year":"2019","journal-title":"CMAJ Open"},{"issue":"8","key":"10.1016\/j.aohep.2024.101509_bib0003","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jama.2017.10304","article-title":"What Is Medicaid? More Than Meets the Eye","volume":"318","author":"Sommers","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2024.101509_bib0004","unstructured":"Centers for Medicare & Medicaid Services. Medicaid Spending by Drug. Published online March 6, 2023. Accessed July 27, 2023.https:\/\/data.cms.gov\/summary-statistics-on-use-and-payments\/medicare-medicaid-spending-by-drug\/medicaid-spending-by-drug"},{"key":"10.1016\/j.aohep.2024.101509_bib0005","unstructured":"Medicaid and CHIP Payment and Access Commission. MACStats: Medicaid and CHIP Data Book. Published online December 2023. Accessed February 12, 2024. https:\/\/www.macpac.gov\/publication\/macstats-compiled\/"},{"issue":"2","key":"10.1016\/j.aohep.2024.101509_bib0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.gastro.2023.08.012","article-title":"Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset","volume":"166","author":"Congly","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2024.101509_bib0007","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jgh.15178","article-title":"Roadmap to resuming care for liver diseases after coronavirus disease-2019","volume":"36","author":"Kapuria","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101509_bib0008","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.annepidem.2014.02.013","article-title":"Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007","volume":"24","author":"Byrne","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101509_bib0009","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","article-title":"Prevalence of Chronic Hepatitis B Virus Infection in the United States","volume":"115","author":"Lim","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101509_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30831","article-title":"Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016","volume":"71","author":"Le","year":"2020","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101509_bib0011","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.cgh.2020.04.091","article-title":"Should Treatment Indications for Chronic Hepatitis B Be Expanded?","volume":"19","author":"Jeng","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101509_bib0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/apt.17052","article-title":"Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis","volume":"56","author":"Lim","year":"2022","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400303X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400303X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:46:01Z","timestamp":1719492361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812400303X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S166526812400303X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101509","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101509"}}